FTADX
Price
$55.83
Change
+$0.13 (+0.23%)
Updated
Jul 3 closing price
Net Assets
11.3B
RERAX
Price
$56.70
Change
+$0.12 (+0.21%)
Updated
Jul 3 closing price
Net Assets
134.48B
Interact to see
Advertisement

FTADX vs RERAX

Header iconFTADX vs RERAX Comparison
Open Charts FTADX vs RERAXBanner chart's image
Fidelity Advisor International Discv M
Price$55.83
Change+$0.13 (+0.23%)
VolumeN/A
Net Assets11.3B
American Funds EUPAC R1
Price$56.70
Change+$0.12 (+0.21%)
VolumeN/A
Net Assets134.48B
FTADX vs RERAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FTADX vs. RERAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTADX is a Buy and RERAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 134B vs. FTADX (11.3B). FTADX pays higher dividends than RERAX: FTADX (1.98) vs RERAX (0.23). FTADX was incepted earlier than RERAX: FTADX (21 years) vs RERAX (23 years). RERAX (1.57) is less costly to investors than FTADX (1.12). FTADX is a more actively managed with annual turnover of: 44.00 vs. RERAX (30.00). FTADX has a lower initial minimum investment than RERAX: FTADX (0) vs RERAX (250). FTADX annual gain was more profitable for investors over the last year : 14.37 vs. RERAX (4.08). FTADX return over 5 years is better than : 34.03 vs. RERAX (12.35).
FTADXRERAXFTADX / RERAX
Total Expense Ratio1.121.5771%
Annual Report Gross Expense Ratio1.121.5771%
Fund Existence21 years23 years-
Gain YTD18.43412.433148%
Front Load4%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets11.3B134B8%
Annual Yield % from dividends1.980.23846%
Returns for 1 year14.374.08352%
Returns for 3 years51.5126.81192%
Returns for 5 years34.0312.35275%
Returns for 10 years46.8321.06222%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPYC42.501.11
+2.69%
Simplify US Equity PLUS Convexity ETF
JMOM64.620.66
+1.03%
JPMorgan US Momentum Factor ETF
SPXX17.970.13
+0.73%
Nuveen S&P 500 Dynamic Overwrite Fund
BBC20.320.13
+0.65%
Virtus LifeSci Biotech Clinical Trls ETF
EFFE21.87N/A
N/A
Harbor Osmosis Emerging Markets Resource Efficient ETF